tonsil, and lung tissue samples from a dead pig. We suspended tissue and fecal samples in Dulbecco's modified Eagle medium and homogenized. These homogenized samples, along with blood samples, were centrifuged at 3,000 rpm for 10 min. We processed the supernatant and serum fractions further.
Total RNA was extracted from 200 μL of serum or supernatant using Qiazol Lysis Reagent (QIAGEN, Germantown, MD, USA) according to the manufacturer's instructions. With the extracted RNA, one-step reverse transcription PCR (RT-PCR) was performed using CSFVspecific primer sets with SuPrimeScript RT-PCR premix (GeNet Bio, Daejeon, South Korea) (online Technical Appendix Table 1 ). The structural genes of the CSFVs from both farms were amplified and sequenced using 2 sets of primers. We aligned the nucleotide sequences encoding the structural proteins with those of reference strains deposited in GenBank and constructed a phylogenetic tree using the maximum-likelihood method with 1,000 bootstrap replicates. The nucleotide sequences of the structural genes of the 2 vaccine-related strains were deposited in GenBank (accession nos. KX954607 and KX954608).
To determine if other pathogens besides CSFV that can also induce reproductive failures were present in the mummified fetus and dead pig, we performed PCR for porcine reproductive and respiratory syndrome virus, porcine circovirus type 2, Aujeszky disease virus, porcine parvovirus, Japanese encephalitis virus, and encephalomyocarditis virus. In brief, viral DNA and RNA was extracted by using Viral Gene-Spin Kit (iNtRON Biotechnology Inc., Seongnam, South Korea) according to the manufacturer's instructions. To detect porcine reproductive and respiratory syndrome virus, we performed conventional RT-PCR using virus-specific primer sets and SuPrimeScript RT-PCR premix (GeNet Bio). To detect porcine circovirus type 2, we performed PCR assays using virus-specific primer sets and HS Prime Taq Premix (GeNet Bio) (online Technical Appendix Table 1 ). In addition, 2 commercially available kits were used to detect Aujeszky disease virus and porcine parvovirus (VDx Abortion MP PCR kit, MEDIAN Diagnostics Inc., Chuncheon, South Korea) and encephalomyocarditis virus and Japanese encephalitis virus (VDx Abortion MP RT-PCR II, MEDIAN Diagnostics Inc.). 
*These mutations were identical to those of vaccine strains bottled in all 5 commercial vaccines (Y.S. Lyoo, unpub. data). 
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